Next Article in Journal
Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Terms of Staging and Treatment Strategies by Dental Students at Different Educational Levels
Next Article in Special Issue
Comparison of BODE and ADO Indices in Predicting COPD-Related Medical Costs
Previous Article in Journal
The Prone Lateral Approach for Lumbar Fusion—A Review of the Literature and Case Series
 
 
Review
Peer-Review Record

The Relationship of Cholesterol Responses to Mitochondrial Dysfunction and Lung Inflammation in Chronic Obstructive Pulmonary Disease

Medicina 2023, 59(2), 253; https://doi.org/10.3390/medicina59020253
by Bakr Jundi, Huma Ahmed, Joshua Reece and Patrick Geraghty *
Reviewer 1:
Reviewer 2: Anonymous
Medicina 2023, 59(2), 253; https://doi.org/10.3390/medicina59020253
Submission received: 6 December 2022 / Revised: 25 January 2023 / Accepted: 26 January 2023 / Published: 28 January 2023
(This article belongs to the Special Issue Update on COPD and Cystic Fibrosis)

Round 1

Reviewer 1 Report

Hello,

Thank you for submitting the manuscript titled “Cholesterol responses linked to mitochondrial dysfunction and lung inflammation in COPD”. Authors have summarized the literature well and presented with cellular changes with figure for mitochondrial dysfunction in COPD. There are further points that authors should consider elucidating the correlation of higher cholesterol accumulation and COPD.

Minor:

1.       As one would expect the lifestyle factor apart from genetic in progression of cholesterol accumulation. Authors should elaborate this area with related literature in COPD, discuss how lifestyle can impact the high cholesterol and worsening the COPD level.

2.       Authors should discuss the pharmacological intervention and success so far in this domain.

3.       Ageing factor can also change the progression of COPD and also metabolism in aged patients vs young patients can be lower in process of cholesterol. Authors should also add some related literature in this area with latest trend.

Thank you

Author Response

Reviewer 1:

 

  1. As one would expect the lifestyle factor apart from genetic in progression of cholesterol accumulation. Authors should elaborate this area with related literature in COPD, discuss how lifestyle can impact the high cholesterol and worsening the COPD level.

Response: We have added several sentences to address this topic. Please see lines 51-58

 

  1. Authors should discuss the pharmacological intervention and success so far in this domain.

Response: We added lines 78-80, and 334-336

 

  1. Ageing factor can also change the progression of COPD and also metabolism in aged patients vs young patients can be lower in process of cholesterol. Authors should also add some related literature in this area with latest trend.

Response: We have the lines 336-340

Reviewer 2 Report

I would suggest to change the title to make it more clear. The title of the paragraph no.4 and 5 is almost the same. Please change and reorganise. Please  highlight and group the animal studies and clinical studies in the sections. Although smoking is the main cause of the COPD, there are also other causes of this disease. The authors should specify and focus on certain pathophysiological links and mechanisms.

Line 50: „this mechanism”

Unclear - Please express more precisely     Line 98: „they also observed” Unclear - Please specify   Line 102: unclear - please correct   Line 126 to colloquial - please correct   Line 148 this is also relevant to humans - please expres more precisely   Line 159 - atorvastatin is also a statin - please correct   Line 188 „in diseases like” to colloquial - please correct    Line 313 „destruction of the lung” - too general, please correct   Please distinguish the limitations of the study section







Author Response

Reviewer 2:

 

I would suggest to change the title to make it more clear.

Response: We have modified the title

 

The title of the paragraph no.4 and 5 is almost the same. Please change and reorganise.

Response: We have removed the title for section 5 and combined both sections.

 

Please  highlight and group the animal studies and clinical studies in the sections.

Response: All animal studies are now clearly labelled.

 

Although smoking is the main cause of the COPD, there are also other causes of this disease. The authors should specify and focus on certain pathophysiological links and mechanisms.

Response: We have added several sentences on alpha-1 antitrypsin deficiency. Please see lines 30-31, and 332-334

 

Line 50: „this mechanism” Unclear - Please express more precisely     Line 98: „they also observed” Unclear - Please specify   Line 102: unclear - please correct   Line 126 to colloquial - please correct   Line 148 this is also relevant to humans - please expres more precisely   Line 159 - atorvastatin is also a statin - please correct   Line 188 „in diseases like” to colloquial - please correct    Line 313 „destruction of the lung” - too general, please correct   Please distinguish the limitations of the study section

Response: We have reorganized these sentences to be clearer

Round 2

Reviewer 2 Report

The authors made the sufficient corrections to the manuscript. Please add inclisiran as a novel therapeutic option in line 336

Author Response

We thank the reviewer for their helpful comments. We have added inclisiran as a novel therapeutic option on line 336

Back to TopTop